PET/CT is significantly more accurate than CT alone, PET alone, and side-by-side CT and PET for evaluating the TNM stage of various malignant diseases. This diagnostic advantage translates into treatment plan changes in a substantial number of patients, according to Dr. Gerald Antoch and colleagues at University Hospital Essen in Germany.
PET/CT is significantly more accurate than CT alone, PET alone, and side-by-side CT and PET for evaluating the TNM stage of various malignant diseases. This diagnostic advantage translates into treatment plan changes in a substantial number of patients, according to Dr. Gerald Antoch and colleagues at University Hospital Essen in Germany.
Researchers viewed scans from 260 consecutive patients (167 female) with different oncologic diseases who had undergone FDG-PET/CT for tumor staging. One hundred twelve patients were imaged for primary tumor staging and 148 for suspected recurrent disease.
The majority of patients had malignant non-small cell lung carcinoma, followed by head and neck tumors, gastrointestinal tumors, and others. The researchers performed PET/CT with an axial field-of-view from head to upper thigh, using intravenous contrast CT for diagnostic data.
Two nuclear medicine specialists viewed the PET-alone images. They evaluated the images first qualitatively by the areas of increased glucose metabolism, then quantitatively by the standard uptake value.
An SUV cutoff value of 2.5 for malignancy was used for all organs except the liver, for which it was 3.5. The difference in cutoff values was based on an analysis of the literature that showed generally higher FDG uptake in the liver than in the rest of the body organs, Antoch said.
Two radiologists examined the CT images and determined whether lymph nodes were metastatic based on their size. Side-by-side images were evaluated by radiologists and nuclear medicine specialists on two different screens: CT on the right screen, PET on the left. The images were purposely misregistered to ensure a degree of objectivity.
The same radiologists and nuclear medicine specialists reviewed the fused images one month after the side-by-side image analysis. Increased glucose metabolism was again used to determine pathology.
The researchers performed a separate analysis for the T-, N-, and M-stages and also determined the impact of PET/CT on patient management.
Histopathology was the standard of reference for 77 patients for the T-stage, 72 patients for the N-stage, and 57 patients for the M-stage. For all other patients, clinical follow-up served as the standard of reference.
Fused PET/CT proved significantly more accurate in assessing the overall TNM stage compared with CT alone, PET alone, and side-by-side CT plus PET.
Of all 260 patients, 84 % were correctly staged with PET/CT, 76% with side-by-side CT plus PET, 64% with PET alone, and 63 % with CT alone.
Sensitivities and specificities for characterization of the N-stage were 92% and 93% for PET/CT, 88% and 89% for CT plus PET, 85% and 88% for PET, and 64% and 83% for CT.
Sensitivities and specificities for assessment of the M-stage were 94% and 97% with PET/CT, 92% and 96% with CT plus PET, 78% and 99% with PET, and 82% and 95% with CT.
"The most important point is whether PET/CT had an impact on patient management," Antoch said. "Does it change patient therapy from palliative to curative, from curative to palliative? Or does it change the surgical approach from extended surgery to limited surgery?"
Combined PET/CT affected the treatment plan for 17% of patients compared with PET alone, for 15% of patients compared with CT alone, and for 6% of patients compared with side-by-side CT plus PET.
What New Research Reveals About Novice Use of AI-Guided Cardiac Ultrasound
April 4th 2025In a study recently presented at the American College of Cardiology (ACC) conference, researchers found that novice use of AI-guided cardiac ultrasound after an AI-enabled electrocardiogram increased the positive predictive value for reduced left ventricular ejection fraction (LVEF) or aortic valve stenosis by 33 percent.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.